THE WIRE
What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Key
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.
- AMPHAmphastar Pharmaceuticals, IncThe CFO, EVP & Treasurer sold $330K of stock under a 10b5-1 plan.$330K−4.9%Form 4 ↗
- PKOHPark Ohio Holdings CorpThe VP & CFO sold $99K of stock under a 10b5-1 plan.$99K−7.4%Form 4 ↗
- FLNAFilana Therapeutics, IncThe Chief Financial Officer bought $8K of stock.$8K+17.7%Form 4 ↗
- FLNAFilana Therapeutics, IncThe Chief Operating& Legal Officer bought $56K of stock.$56K+17.7%Form 4 ↗
- GEGeneral Electric CoThe Senior Vice President sold $657K of stock.$657K−5.6%Form 4 ↗
- YELPYelp IncOther events.−9.0%8-K 8.01 ↗
- INHDInno Holdings IncMaterial agreement.−4.3%8-K 1.01 ↗
- CPBCAMPBELL'S CoOfficer or director change and shareholder vote.−2.4%8-K 5.02 ↗
- RRGBRed Robin Gourmet Burgers IncResults of operations.
RED ROBIN GOURMET BURGERS, INC. REPORTS THIRD QUARTER OF FISCAL 2026 RESULTS
−25.2%8-K 2.02 ↗ - RSKDRiskified LTDA director sold $720K of stock.$720K−3.4%Form 4 ↗
- UTZUtz Brands, IncShareholder vote.+0.2%8-K 5.07 ↗
- REGNRegeneron Pharmaceuticals, Inc2 officers sold $5.3M of stock, all under plans set in advance.$5.3M−2.6%
- REGNRegeneron Pharmaceuticals, IncThe EVP Commercial sold $544K of stock under a 10b5-1 plan.$544K−2.6%Form 4 ↗
- REGNRegeneron Pharmaceuticals, IncThe Co-Chief Scientific Officer sold $4.8M of stock under a 10b5-1 plan.$4.8M−2.6%Form 4 ↗
- RWAYRunway Growth Finance CorpThe CFO, Treasurer and Secretary bought $7K of stock.$7K−4.0%Form 4 ↗
- EPAMEPAM Systems, IncThe Chief Financial Officer sold $546K of stock.$546K−0.6%Form 4 ↗
- HPEHewlett Packard Enterprise CoMaterial agreement and officer or director change.−10.6%8-K 1.01 ↗
- ALTAltimmune, IncThe Principal Accounting Officer bought $14K of stock.$14K−4.3%Form 4 ↗
- HBBHamilton Beach Brands Holding CoOfficer or director change and Regulation FD disclosure.−4.5%8-K 5.02 ↗
- SELFGlobal Self Storage, IncA director bought $5K of stock.$5K−2.1%Form 4 ↗
- STWDStarwood Property Trust, IncA director bought $2.0M of stock.$2.0M−4.0%Form 4 ↗
- CSTLCastle Biosciences IncThe Pres. & Chief Exec. Officer sold $229K of stock under a 10b5-1 plan.$229K−1.6%Form 4 ↗
- INTAIntapp, IncThe Chief Executive Officer sold $140K of stock under a 10b5-1 plan.$140K−1.8%Form 4 ↗
- UTIUniversal Technical Institute IncResults of operations and Regulation FD disclosure.
Universal Technical Institute Reports Fiscal Year 2026 Fourth Quarter and Year-End Results Company Unveils Next-Generation UTI Campus, Skilled Trades Max, and Details Plan for Up to 12 New Campuses…
−22.1%8-K 2.02 ↗ - PEverpure, IncResults of operations.
Everpure Announces Third Quarter Fiscal 2027 Financial Results Total revenue growth of 51% year-over-year Increased FY27 revenue and operating income guidance
−8.6%8-K 2.02 ↗ - HAYWHayward Holdings, IncThe SVP, CLO, Corporate Secretary sold $132K of stock under a 10b5-1 plan.$132K−4.1%Form 4 ↗
- ARTVArtiva Biotherapeutics, IncThe President & Head of R&D sold $4K of stock.$4K+0.3%Form 4 ↗
- ARTVArtiva Biotherapeutics, IncThe Chief Tech Operations Officer sold $80K of stock.$80K+0.3%Form 4 ↗
- ARTVArtiva Biotherapeutics, IncThe COO, CLO, Compliance Officer sold $75K of stock.$75K+0.3%Form 4 ↗
- KLICKulicke & Soffa Industries IncResults of operations.−18.3%8-K 2.02 ↗
- COFCapital One Financial Corp2 officers sold $730K of stock, all under plans set in advance.$730K−3.1%
- COFCapital One Financial CorpThe Pres, Retail Bank sold $367K of stock under a 10b5-1 plan.$367K−3.1%Form 4 ↗
- COFCapital One Financial CorpThe Pres, Banking & Prem. Products sold $363K of stock under a 10b5-1 plan.$363K−3.1%Form 4 ↗
- NCDLNuveen Churchill Direct Lending CorpA director bought $17K of stock.$17K−0.4%Form 4 ↗
- NDAQNasdaq, IncOfficer or director change.−2.6%8-K 5.02 ↗
- SBFMSunshine Biopharma IncRegistration of new shares.−7.5%S-1 ↗
- CORZCore Scientific, Inc./txAn officer sold $136K of stock under a 10b5-1 plan.$136K−19.4%Form 4 ↗
- PVLPermianville Royalty TrustResults of operations.−6.7%8-K 2.02 ↗
- RNGRingCentral, IncThe Chief Financial Officer sold $126K of stock under a 10b5-1 plan.$126K−6.4%Form 4 ↗
- TWSTTwist Bioscience CorpAn officer sold $563K of stock.$563K−11.2%Form 4 ↗
- TWSTTwist Bioscience CorpThe President and COO sold $1.3M of stock.$1.3M−11.2%Form 4 ↗
- TWSTTwist Bioscience CorpThe SVP of Human Resources sold $444K of stock.$444K−11.2%Form 4 ↗
- TWSTTwist Bioscience CorpThe Chief Executive Officer sold $2.0M of stock.$2.0M−11.2%Form 4 ↗
- TWSTTwist Bioscience CorpThe Chief Accounting Officer sold $170K of stock.$170K−11.2%Form 4 ↗
- TWSTTwist Bioscience CorpThe Chief Financial Officer sold $659K of stock.$659K−11.2%Form 4 ↗
- MBINMerchants BancorpOther events.−4.7%8-K 8.01 ↗
- SYYSysco CorpShareholder vote.+0.3%8-K 5.07 ↗
- KURAKura Oncology, IncThe SVP, Finance & Accounting sold $35K of stock.$35K−5.9%Form 4 ↗
- KURAKura Oncology, IncThe Chief Medical Officer sold $307K of stock.$307K−5.9%Form 4 ↗
- KURAKura Oncology, IncThe Chief Commercial Officer sold $182K of stock.$182K−5.9%Form 4 ↗
- WMSAdvanced Drainage Systems, IncA director sold $2.4M of stock.$2.4M−6.9%Form 4 ↗
- TRAKReposiTrak, IncResults of operations and Regulation FD disclosure.
ReposiTrak Announces SPAR Group Transaction and Reports First Quarter Fiscal 2027 Results
−4.1%8-K 2.02 ↗